PKC stimulated by glucagon decreases UT-A1 urea transporter expression in rat IMCD

被引:0
|
作者
Yuristella Yano
Adilson C. Rodrígues
Ana C. de Bragança
Lucia C. Andrade
Antonio J. Magaldi
机构
[1] Universidade de São Paulo,Laboratório de Pesquisa Básica
来源
Pflügers Archiv - European Journal of Physiology | 2008年 / 456卷
关键词
Glucagon; UT-A1; Membrane transport proteins/urea transport; Glucagon antagonist; Vasopressin; PKC; PMA; Staurosporin;
D O I
暂无
中图分类号
学科分类号
摘要
It is well-known that glucagon increases fractional excretion of urea in rats after a protein intravenous infusion. This effect was investigated by using: (a) in vitro microperfusion technique to measure [14C]-urea permeability (Pu × 10−5cm/s) in inner medullary collecting ducts (IMCD) from normal rats in the presence of 10−7M of glucagon and in the absence of vasopressin and (b) immunoblot techniques to determine urea transporter expression in tubule suspension incubated with the same glucagon concentration. Seven groups of IMCDs (n = 47) were studied. Our results revealed that: (a) glucagon decreased urea reabsorption dose-dependently; (b) the glucagon antagonist des-His1-[Glu9], blocked the glucagon action but not vasopressin action; (c) the phorbol myristate acetate, decreased urea reabsorption but (d) staurosporin, restored its effect; e) staurosporin decreased glucagon action, and finally, (f) glucagon decreased UT-A1 expression. We can conclude that glucagon reduces UT-A1 expression via a glucagon receptor by stimulating PKC.
引用
收藏
页码:1229 / 1237
页数:8
相关论文
共 29 条
  • [21] Regulation of glucose transporter 1 expression by gliclazide in rat L6 myoblasts
    Imamura, H
    Morimoto, I
    Tanaka, Y
    Hashimoto, O
    Kanda, K
    Yamashita, S
    Eto, S
    DIABETES NUTRITION & METABOLISM, 2001, 14 (06) : 308 - 314
  • [22] PKC pathway associated with the expression of an A-type K+ channel induced by TGF-β1 in rat vascular myofibroblasts
    Liao, L
    Zeng, XM
    Gao, PJ
    Zhu, DL
    Mei, YA
    BIOCHEMICAL AND BIOPHYSICAL RESEARCH COMMUNICATIONS, 2005, 336 (03) : 854 - 859
  • [23] Glucagon phosphorylates serine 552 of β-catenin leading to increased expression of cyclin D1 and c-Myc in the isolated rat liver
    Chowdhury, Md. Kamrul H.
    Montgomery, Magda K.
    Morris, Margaret J.
    Cognard, Emmanuelle
    Shepherd, Peter R.
    Smith, Greg C.
    ARCHIVES OF PHYSIOLOGY AND BIOCHEMISTRY, 2015, 121 (03) : 88 - 96
  • [24] New perspectives of vesicular monoamine transporter 2 chemical characteristics in mammals and its constant expression in type 1 diabetes rat models
    Hong, Feng
    Liu, Li
    Fan, Rui-Fang
    Chen, Ye
    Chen, Hui
    Zheng, Rui-Pan
    Zhang, Yue
    Gao, Yan
    Zhu, Jin-Xia
    TRANSLATIONAL RESEARCH, 2014, 163 (02) : 171 - 182
  • [25] Activation of P2X7 purinoceptor-stimulated TGF-β1 mRNA expression involves PKC/MAPK signalling pathway in a rat brain-derived type-2 astrocyte cell line, RBA-2
    Wang, CM
    Chang, YY
    Sun, SH
    CELLULAR SIGNALLING, 2003, 15 (12) : 1129 - 1137
  • [26] Action of glucagon-like peptide 1 and glucose levels on corticotropin-releasing factor and vasopressin gene expression in rat hypothalamic 4B cells
    Kageyama, Kazunori
    Yamagata, Satoshi
    Akimoto, Kanako
    Sugiyama, Aya
    Murasawa, Shingo
    Suda, Toshihiro
    MOLECULAR AND CELLULAR ENDOCRINOLOGY, 2012, 362 (1-2) : 221 - 226
  • [27] Apelin-13 upregulates Egr-1 expression in rat vascular smooth muscle cells through the PI3K/Akt and PKC signaling pathways
    Liu, Qi-Feng
    Yu, Hong-Wei
    Sun, Li-Li
    You, Lu
    Tao, Gui-Zhou
    Qu, Bao-Ze
    BIOCHEMICAL AND BIOPHYSICAL RESEARCH COMMUNICATIONS, 2015, 468 (04) : 617 - 621
  • [28] A1-42 increases the expression of neural KATP subunits Kir6.2/SUR1 via the NF-B, p38 MAPK and PKC signal pathways in rat primary cholinergic neurons
    Li, Y.
    Ba, M.
    Du, Y.
    Xia, C.
    Tan, S.
    Ng, K. P.
    Ma, G.
    HUMAN & EXPERIMENTAL TOXICOLOGY, 2019, 38 (06) : 665 - 674
  • [29] Resveratrol protects against hepatic insulin resistance in a rat's model of non-alcoholic fatty liver disease by down-regulation of GPAT-1 and DGAT2 expression and inhibition of PKC membranous translocation
    Badi, Rehab M.
    Mostafa, Dalia G.
    Khaleel, Eman F.
    Satti, Huda H.
    CLINICAL AND EXPERIMENTAL PHARMACOLOGY AND PHYSIOLOGY, 2019, 46 (06) : 545 - 555